Glucocorticoids in the treatment of early and late RA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Dietary Interventions with or without Omega-3 Supplementation for the Management of Rheumatoid Arthritis: A Systematic Review.Nutrients · 2021
   Pooled it
2. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2006
   Trial
3. Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.PloS one · 2023
   Article
4. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Rheumatoid Arthritis (MEDRA): Study protocol.Contemporary clinical trials communications · 2022
   Article
5. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.Rheumatology (Oxford, England) · 2022
   Article
6. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis.Nature communications · 2021
   Article
7. Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis.ClinicoEconomics and outcomes research : CEOR · 2021
   Article
8. Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial.Rheumatology and therapy · 2020
   Article
9. Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice.Rheumatology and therapy · 2019
   Article
10. Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.Arthritis care & research · 2018
    Article
11. One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy.RMD open · 2016
    Article
12. Glucocorticoids: bad or safe for the bones?RMD open · 2015
    Article
13. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Article
14. Depicting and comparing the time to normalize "erythrocyte sedimentation rate" following two combination therapies in rheumatoid arthritis patients: a randomized clinical trial.Caspian journal of internal medicine · 2013
    Article
15. Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.Current therapeutic research, clinical and experimental · 2012
    Article
16. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.The American journal of gastroenterology · 2012
    Article
17. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.JAMA · 2011
    Article
18. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.Arthritis care & research · 2011
    Article
19. Suppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.British journal of pharmacology · 2010
    Article
20. Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission.Arthritis care & research · 2010
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as